Cargando…
Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
A treatment strategy of a difficult and unusual problem is presented. We are reporting a case of a patient who had a documented allergy to heparin and required Cardiac surgery for an ASD closure. The anticoagulation regime used during cardiopulmonary bypass was lepirudin based. This report indicates...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079612/ https://www.ncbi.nlm.nih.gov/pubmed/21477293 http://dx.doi.org/10.1186/1749-8090-6-44 |
_version_ | 1782202028079972352 |
---|---|
author | Parissis, Haralabos |
author_facet | Parissis, Haralabos |
author_sort | Parissis, Haralabos |
collection | PubMed |
description | A treatment strategy of a difficult and unusual problem is presented. We are reporting a case of a patient who had a documented allergy to heparin and required Cardiac surgery for an ASD closure. The anticoagulation regime used during cardiopulmonary bypass was lepirudin based. This report indicates that r-hirudin provides effective anticoagulation, however unless ECT is monitoring, post operative hemorrhage is encountered. Therefore this case is unique not only because of its rarity but also by the fact that it presents the caveats encountered when ECT is not available. |
format | Text |
id | pubmed-3079612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30796122011-04-20 Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass Parissis, Haralabos J Cardiothorac Surg Case Report A treatment strategy of a difficult and unusual problem is presented. We are reporting a case of a patient who had a documented allergy to heparin and required Cardiac surgery for an ASD closure. The anticoagulation regime used during cardiopulmonary bypass was lepirudin based. This report indicates that r-hirudin provides effective anticoagulation, however unless ECT is monitoring, post operative hemorrhage is encountered. Therefore this case is unique not only because of its rarity but also by the fact that it presents the caveats encountered when ECT is not available. BioMed Central 2011-04-08 /pmc/articles/PMC3079612/ /pubmed/21477293 http://dx.doi.org/10.1186/1749-8090-6-44 Text en Copyright ©2011 Parissis; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Parissis, Haralabos Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass |
title | Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass |
title_full | Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass |
title_fullStr | Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass |
title_full_unstemmed | Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass |
title_short | Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass |
title_sort | lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079612/ https://www.ncbi.nlm.nih.gov/pubmed/21477293 http://dx.doi.org/10.1186/1749-8090-6-44 |
work_keys_str_mv | AT parissisharalabos lepirudinasanalternativetoheparinallergyduringcardiopulmonarybypass |